Health
National pharmacare – might it be a pig in a poke?

From the Macdonald Laurier Institute
By Nigel Rawson and John Adams for Inside Policy
No Canadian should have to choose between paying for medicines and paying for rent or food. National pharmacare has been proposed as a remedy to this situation.
“When will Canada have national pharmacare?” asks the author of a recent article in the British Medical Journal (BMJ). Better questions are: will Canadian pharmacare be the system many Canadians hope for? Or, might it turn out to be skimpy coverage akin to minimum wage laws?
In its 2024 budget document, the federal government proposed providing $1.5 billion over five years to support the launch of national pharmacare for “universal, single-payer coverage for a number of contraception and diabetes medications.” This has been hailed as a “big day for pharmacare” by some labour unions, patients and others, including the author of the BMJ article who said that national pharmacare should be expanded to cover all medication needs beginning with the most commonly-prescribed, clinically-important “essential medicines.”
In its budget, the government stated “coverage of contraceptives will mean that nine million women in Canada will have better access to contraception” and “improving access to diabetes medications will help improve the health of 3.7 million Canadians with diabetes.” Why not salute such affable, motherhood and apple pie, sentiments? The devil is in the details.
The plan does not cover new drugs for diabetes, such as Ozempic, Rybelsus, Wegovy, Mounjaro or Zepbound, all based on innovative GLP-1 agonists, where evidence is building for cardiovascular and weight loss benefits. This limited rollout seems based on cheap, older medicines, which can be less effective for some with diabetes.
The federal government has also consistently under-estimated the cost of national proposals such as pharmacare – not to mention other promises. In their 2019 election platform, the Liberals promised $6 billion for national pharmacare (the NDP promised $10 billion). Keen analysis shows that even these expansive amounts would be woefully inadequate to fund a full national pharmacare plan. This makes the $300 million a year actually proposed by the Liberals’ look like the skimpy window-dressing that it is.
National pharmacare, based on the most comprehensive existing public drug plan (Quebec’s), would cost much more. In 2017, using optimistic assumptions, the Parliamentary Budget Officer (PBO) estimated the cost for a national plan based on Quebec’s experience to be $19.3 billion a year. With more appropriate assumptions, the Canadian Health Policy Institute estimated $26.2 billion. In June 2019, the federal government’s own Advisory Council on the Implementation of National Pharmacare put the cost at $40 billion, while a few months later, the tax consulting company RSM Canada projected $48.3 to $52.5 billion per year. Five years later, costs no doubt have soared.
Even with these staggering cost a program based on matching Quebec’s drug plan at the national level would fail to provide anywhere near the level of coverage already provided to the almost two-thirds of Canadians who have private drug insurance, including many in unionized jobs. Are they willing to sacrifice their superior coverage, especially of innovative brand-name medicines, for a program covering only “essential medicines”? Put another way, are Canadians and their unions prepared to settle for the equivalent of a minimum wage or minimum benefits?
The PBO has estimated the cost of coverage of a range of contraceptives and diabetes medicines as $1.9 billion over five years, which is more than the $1.5 billion provided in the budget. However, this figure is based on an assumption that the new program would only cover Canadians who currently do not have public or private drug plan insurance, those who currently do not fill their prescriptions due to cost related reasons, and the out-of-pocket part of prescription costs for Canadians who have public or private drug plan coverage. This is major guesswork because existing public and private drug plans may see the new federal program as an opportunity to reduce their costs by requiring their beneficiaries to use the new program. If this occurs, the national pharmacare costs to the federal government, even for the limited role out of diabetes and contraceptives, would soar to an estimated $5.7 billion, according to the PBO.
Our governments are not known for accurate estimates of the costs of new programs. One has only to remember the Phoenix pay system and the ArriveCAN costs. In 2017, the Government of Ontario estimated $465 million per year to extend drug coverage to every resident under the age of 25 years. What happened? Introduced in 2018, prescriptions rose by 290% and drug expenditure increased to $839 million – almost double the guesstimate. In 2019, the provincial government back peddled and modified the program to cover only people not already insured by a private plan.
Although we believe governments should facilitate access to necessary medicines for Canadians who cannot afford their medicines, this does not require national pharmacare and a growing bureaucracy. Exempting lower-income Canadians from copayments and premiums required by provincial programs, as British Columbia has done, and removing the requirement to pay for all drugs up to a deductible would allow these Canadians access sooner, more simply, and more effectively.
Moreover, it isn’t just lower-income Canadians who want help with unmet medicine needs. Canadians who need access to drugs for diseases that are difficult to treat and can cost hundreds of thousands of dollars per year also require assistance. Few Canadians whether they have low, medium or high incomes can afford these prices without government or private insurance. Private insurers often refuse to cover these drugs.
The Liberals provided a separate $1.5 billion over three years for drugs for rare disorders, but no province or territory has signed a bilateral agreement with the federal government for these drugs and no patient has received benefit through this program. Even if they did, the $500 million per year would not go far towards the actual costs. There is at least a zero missing in the federal contribution, as the projected cost of public spending on rare disease medicines by 2025 is more than threefold what Ottawa has budgeted.
Expensive drugs for cancer and rare disorders are just as essential as basic medicines for cardiovascular diseases, diabetes, birth control, and many other common conditions. If a costly medicine will allow a person with a life-shortening disease to live longer or one with a disorder that will be severely disabling left untreated to have an improved quality of life and be a productive taxpayer, it too should be regarded as essential.
The Liberals and NDP are working to stampede the bill to introduce the pharmacare program (Bill C-64) through the legislative process. This includes inviting witnesses over the first long weekend of summer, when many Canadians are away, to appear before the parliamentary Standing Committee on Health three days later.
Too much is unknown about what will be covered (will newer drugs be covered or only older, cheaper medicines?), who will be eligible for coverage (all appropriate Canadians regardless of existing coverage or only those with no present coverage?), and what the real cost will be, including whether a new program focusing on older, cheaper drugs will deter drug developers from launching novel medicines for unmet needs in Canada.
This Bill as it stands is such a power grab that, if passed, the federal Health Minister never has to come back to Parliament for review, oversight or another tranche of legal authority, it would empower the Cabinet to make rules and regulations without parliamentary scrutiny.
A lot is at stake for Canadians, especially for patients and their doctors. Prescription medicines are of critical importance to treating many diseases. National pharmacare must not only allow low-income residents to access purported “essential medicines” but also ensure that patients who need specialized drugs, especially higher-cost innovative cell and genetic therapies that may be the only effective treatment for their disorder, are not ignored. Canadians should be careful what they wish for. They may receive less than they anticipate, and, in fact, many Canadians may be worse off despite the increase in public spending. Time to look under the hood and kick the tires.
Nigel Rawson is a senior fellow with the Macdonald-Laurier Institute.
John Adams is co-founder and CEO of Canadian PKU and Allied Disorders Inc., a senior fellow with the Macdonald-Laurier Institute and volunteer board chair of Best Medicines Coalition.
Health
Selective reporting on measles outbreaks is a globalist smear campaign against Trump administration.

From LifeSiteNews
Ontario has a larger outbreak than Texas. European cases dwarf the Texas outbreak. But the World Health Organization has launched a travel advisory for the United States.
In the currently ongoing outbreak, there have been about 572 measles cases in Ontario, Canada. This is a significantly larger outbreak than the currently hyped one in Texas, which has about 422 cases. The mainstream media has almost completely ignored the Ontario outbreak – their reporting has only focused on the Texas outbreak.
Ontario’s top public health official, Dr. Kieran Moore, does not recommend mandatory vaccination and says the standard public health measures to limit the spread are working. This is a very reasonable response, yet when Sec. Kennedy says something similar; he is viciously attacked.
It is evident by the mainstream media response to the Ontario outbreak versus the Texas outbreak that this is yet another example of the liberal media/pharma machine harassing Kennedy and President Trump.
However, this reporting has an even more sinister aspect – as the media appears to have taken their lead from the World Health Organization.
The World Health Organization has launched a travel advisory for the United States. See the screenshots below (the first screenshot is from an AI summarizer at BRAVE and the second one is from the WHO website):
But what about Canada’s outbreak? Why isn’t Canada mentioned in the travel advisory? Was it an oversight? Did the WHO release a travel advisory just for Canada?
The answer is that the WHO has not put out a travel advisory for Canada, or Ontario, Canada.
In fact, the AI summarizer at BRAVE is clear that the WHO doesn’t put out travel advisories for individual countries, like Canada… The new normal is that the WHO puts out special advisories only for the United States <insert sarcasm>.
And in fact, a search on the WHO website yields not a single mention of the measles outbreak in Canada.
In fact, the WHO places the 422 measles cases in the United States on par with the earthquake in Myanmar, which may have killed up to 10,000 people, all told.
But somehow the 572 cases of measles in Canada don’t deserve a mention.
But wait – the story gets even more bizarre.
The European Region, which includes central Asia, continues to have a significantly high number of measles cases.
The WHO European Region has a population of approximately 745 million people, and had about 127,350 measles cases last year, or 1 in 5,850 people.
Yet – crickets from mainstream media on this factoid.
Why the outcry over 422 measles in Texas?
Here are some ideas:
- To reduce support for RFK Jr., Trump, and MAHA by the American people.
- To scare parents into vaccinating.
- To increase the money going to public health for vaccine stockpiling.
- To support the liberal left in their obsessive hatred of anything MAHA.
- Because the WHO put out a travel advisory.
In the meantime, the WHO has announced that, despite budgetary cuts, they have a $2.5 billion gap for 2025-2027. WHO Director General Tedros correctly blamed Trump for the deficit. However, what Tedros gets wrong is that this deficit is a well-deserved consequence of years of corruption at the WHO leading to this outcome.
This is how it is done, folks.
This is called retaliation by the World Health Organization against the Trump administration.
Another wrap-up smear in action. The deep state and the globalists are pulling out all the stops to attack Trump and Kennedy via “trumped-up” WHO travel advisories and emergency reports that are then reported on breathlessly and uncritically by mainstream media. The propaganda machine continues unabated.
Reprinted with permission from Robert Malone.
COVID-19
Trump’s new NIH head fires top Fauci allies and COVID shot promoters, including Fauci’s wife

From LifeSiteNews
“During the pandemic Fauci’s bioethicist wife, Christine Grady, offered nurses a choice: Get vaccinated, or lose your job,” noted The COVID-19 History Project on X. “Yesterday, she was offered a choice: Transfer to an office in Alaska, or lose your job. What’s fair is fair. Everyone deserves a choice,” explained the COVID watchdog account.
On day one of his new job as head of the National Institutes of Health (NIH), Dr. Jay Bhattacharya removed four powerful agency heads, including Dr. Anthony Fauci’s wife, Christine Grady, and others associated with the questionable handling of the COVID-19 shots.
Grady, who had served as chief of the agency’s Department of Bioethics, and other longtime Fauci allies in top posts at the NIH involved in the development and distribution of the untested COVID shots produced by Big Pharma were offered jobs in Alaska and other remote locales far away from the NIH’s sprawling Bethesda, Maryland, complex just outside Washington, D.C.
The purge came amid massive layoffs in health-related agencies under the umbrella of Health and Human Services (HHS), now headed by the Make America Healthy Again (MAHA) movement’s founder, Robert F. Kennedy Jr., who has long questioned vaccine safety and American medicine’s focus on treating disease rather than preventing it.
A total of about 20,000 personnel – mostly bureaucrats – or about 25 percent of the HHS workforce have been or will be handed pink slips amid Kennedy’s realignment of the agency.
MAHA critics were quick to call Tuesday’s axing of Fauci confederates as “one of the darkest days in modern scientific history” fueled by Kennedy’s desire to exact revenge on Fauci’s former trusted associates who represent the antithesis of the MAHA movement.
However, the revamping of the federal government’s side of the health industry is no more harsh than the treatment meted out by those formerly in control who, at best, suppressed, and worst, punished those who questioned their iron grip on health-industry regulations and standards.
For years, Kennedy’s critics have dismissed his quest to revamp healthcare and his questioning of the efficacy of the COVID-19 mRNA jabs as anti-science, labeling him as an “anti-vaxxer” in order to suppress his messaging.
Dr. Francis Collins – whom Bhattacharya replaced as head of NIH – in an October 2020 email to Fauci condemned Bhattacharya as a “fringe epidemiologist” because he had co-authored the Great Barrington Declaration, which criticized harmful COVID lockdown policies.
“During the pandemic Fauci’s bioethicist wife, Christine Grady, offered nurses a choice: Get vaccinated, or lose your job,” noted The COVID-19 History Project on X.
“Yesterday, she was offered a choice: Transfer to an office in Alaska, or lose your job. What’s fair is fair. Everyone deserves a choice,” explained the COVID watchdog account.
“We spend 4X more than Italy on healthcare — and live 7 years less. Dead last in cancer rates. This isn’t science — it’s a system profiting off sick kids,” explained Calley Means, RFK Jr. HHS advisor during an interview with Laura Ingraham following the NIH firings.
“Firing the people who oversaw this? That’s step one,” declared Means.
Other NIH officials who were offered reassignments were Dr. Jeanne Marrazzo, who succeeded Fauci as head of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Clifford Lane, a close Fauci ally who served as deputy director for clinical research at NIAID, and Dr. Emily Erbelding, NIAID’s microbiology and infectious diseases director.
-
2025 Federal Election6 hours ago
Mark Carney refuses to clarify 2022 remarks accusing the Freedom Convoy of ‘sedition’
-
2025 Federal Election10 hours ago
Poilievre To Create ‘Canada First’ National Energy Corridor
-
Bruce Dowbiggin8 hours ago
Are the Jays Signing Or Declining? Only Vladdy & Bo Know For Sure
-
2025 Federal Election9 hours ago
Fixing Canada’s immigration system should be next government’s top priority
-
Daily Caller7 hours ago
Biden Administration Was Secretly More Involved In Ukraine Than It Let On, Investigation Reveals
-
Freedom Convoy2 days ago
Freedom Convoy leaders Tamara Lich, Chris Barber found guilty of mischief
-
COVID-192 days ago
Trump’s new NIH head fires top Fauci allies and COVID shot promoters, including Fauci’s wife
-
2025 Federal Election2 days ago
Poilievre promises to drop ‘radical political ideologies’ in universities